Injective INJ
Rank #97Injective Overview
As of October 17, 2026, Injective (INJ) is trading at $7.66, up 0.14% over the past 24 hours. It ranks #97 by market capitalisation, currently valued at $748.60M, on $79.90M of trading volume in the last 24 hours.
Injective Price Chart Binance
Performance
Market Metrics
Technical Analysis live indicator readings
Moving Averages
Oscillators
Support & Resistance daily pivot levels
All indicators are computed from Binance daily OHLC. This is a summary of current technical readings (overbought/oversold & trend model) — not a price forecast, and not investment advice.
Correlations 90-day, vs majors
Pearson correlation of daily returns over the last 90 days (Binance). +1 moves together, 0 unrelated, −1 moves opposite.
Derivatives Hyperliquid perps
Markets Binance spot
| Pair | Price | 24h Volume |
|---|---|---|
| INJ/USDT | $8.57 | ≈ $15.21M |
| INJ/USDC | $8.55 | ≈ $2.73M |
| INJ/TRY | 424.1 TRY | ≈ $1.85M |
| INJ/TUSD | $26.23 | ≈ $550.2K |
| INJ/BNB | 0.004703 BNB | ≈ $470.6K |
| INJ/ETH | 0.001559 ETH | ≈ $458.2K |
| INJ/BTC | 0.00010522 BTC | ≈ $165.8K |
Live spot pairs on Binance, ranked by USD-equivalent 24-hour volume. For information only.
Price History last 30 days
| Date | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| Loading… | |||||
INJ Calculators
Injective Price in Other Currencies
Converted from USD at European Central Bank reference rates (frankfurter.app), updated daily.
Compare with Top Coins
| Coin | Price | 24h | Market Cap |
|---|---|---|---|
| BitcoinBTC | $83,860.05 | −0.37% | $1.68T |
| EthereumETH | $2,693.01 | −1.05% | $328.80B |
| TetherUSDT | $0.9998 | +0.01% | $183.84B |
| BNBBNB | $768.72 | +0.50% | $102.36B |
| XRPXRP | $1.51 | +0.15% | $95.49B |
| USDCUSDC | $1.00 | +0.02% | $74.37B |
| SolanaSOL | $119.74 | +0.05% | $70.41B |
| InjectiveINJ | $7.66 | +0.14% | $748.60M |
Market Sentiment
Popular Injective searches
Market data is aggregated from public sources (Binance, CoinPaprika, Hyperliquid, Polymarket, alternative.me) for informational purposes only and may be delayed. This is not investment advice.